"Tumefactive MS lesions may mimic tumors and manifest mass effect, edema, and an open ring enhancement," the case authors said. Tumefactive MS accounts for an estimated 1-3 of 1,000 cases of MS, and ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Elevated EBNA-1 peptide antibody titers were substantially more prevalent in RRMS than in MOGAD, NMOSD, other inflammatory neurologic diseases, other neurologic diseases, or healthy controls.

A cross-sectional, prospective study found that gray matter atrophy was more prevalent in patients with more severe progressive multiple sclerosis (MS) compared with those with less severe progressive ...

In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...